Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02609841 · ClinicalTrials.gov registry record
POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study
A clinical trial, sponsored by ZS Pharma.
- Completed
- Registry status
- 240
- Enrollment target
NCT02609841 is a clinical trial that has completed, run by ZS Pharma. The registered enrollment target is 240 participants.
The verdict
NCT02609841 has completed, sponsored by ZS Pharma.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
This study assesses serum potassium and cardiac rhythm trends in subjects with end stage renal disease (ESRD) who are on 3 times weekly maintenance hemodialysis for at least 60 days. Dialysate K (relative potassium concentration in dialysate) must be stable for 2 weeks prior to enrollment.The number of subjects on 3K or higher dialysate will be limited to 60, with the remainder of the subjects on 1K or 2K dialysate.
Interventions
- DEVICE Cardiac rhythm remote monitoring system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2015-09-30 |
| Est. Completion | 2016-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02609841
The ClinicalTrials.gov registry entry for NCT02609841 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZS Pharma, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac rhythm remote monitoring system is the first listed.
NCT02609841 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02609841 about?
NCT02609841 is a clinical study titled "POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study". This study assesses serum potassium and cardiac rhythm trends in subjects with end stage renal disease (ESRD) who are on 3 times weekly maintenance hemodialysis for at least 60 days. Dialysate K (relative potassium concentration in dialysate) must be stable for 2 weeks prior to enrollment.The number...
What is the current status of trial NCT02609841?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2015-09-30. Estimated completion is 2016-05-31.
What interventions are being tested in trial NCT02609841?
The interventions under investigation include: Cardiac rhythm remote monitoring system (DEVICE).
Who is sponsoring clinical trial NCT02609841?
This trial is sponsored by ZS Pharma, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.